Artificial Intelligence–Driven Novel Drug Discovery: Target Identification to Translational Impact
Journal of Integrative and Translational Biomedicine · 26.02.2026 · 1 (1) · 09-14
DOI: 10.67316/jintb.v1.i1.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative and Translational Biomedicine, online erschienen am 26.02.2026. Verfasst von Bijendra K. Mandar. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Increasing complexity of biomedical data and high attrition rates associated with conventional drug development has driven the adoption of artificial intelligence (AI) as a strategic tool in novel drug discovery. AI-based approaches enable systematic analysis of biological systems, support accurate identification of therapeutic targets, and facilitate efficient exploration of chemical space for hit and lead discovery. By guiding lead optimization and enabling early assessment of pharmacokinetic and safety profiles, AI contributes to more informed decision-making throughout drug discovery pipeline. Beyond early-stage development, AI enhances translational research by supporting biomarker identification and patient stratification. Although challenges related to data quality, model interpretability, and validation remain, integration of AI with experimental and clinical expertise offers a promising pathway toward more efficient, robust, and patient-relevant drug discovery.
Zitieren
APA
Mandar, B. K. (2026). Artificial Intelligence–Driven Novel Drug Discovery: Target Identification to Translational Impact. Journal of Integrative and Translational Biomedicine, 1(1), 09-14. https://doi.org/10.67316/jintb.v1.i1.9
Vancouver
Mandar BK. Artificial Intelligence–Driven Novel Drug Discovery: Target Identification to Translational Impact. Journal of Integrative and Translational Biomedicine. 2026;1(1):09-14. doi:10.67316/jintb.v1.i1.9
BibTeX
@article{Mandar2026,
author = {Mandar, Bijendra K.},
title = {Artificial Intelligence–Driven Novel Drug Discovery: Target Identification to Translational Impact},
journal = {Journal of Integrative and Translational Biomedicine},
year = {2026},
volume = {1},
number = {1},
pages = {09--14},
doi = {10.67316/jintb.v1.i1.9}
}
EUVIMED